Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | MRNA | BMY | AMGN | GILD |
| Company | Albireo Pharma Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 44.90 | 103.31 | 48.61 | 266.75 | 67.74 |
| High | 44.90 | 103.31 | 48.61 | 266.75 | 67.74 |
| Low | 43.99 | 103.31 | 48.61 | 266.75 | 67.74 |
| Last | 44.15 | 103.31 | 48.61 | 266.75 | 67.74 |
| Change | -0.10 | -0.55 | +0.10 | +1.24 | -0.01 |
| % Change | -0.23% | -0.53% | +0.21% | +0.47% | -0.01% |
| Volume | 1,241,200 | 6,863 | 2,937 | 1,287 | 2,296 |
| 20-Day Average Volume | 635,260 | 3,268,823 | 10,940,592 | 2,168,304 | 6,178,430 |
| Previous Close | 44.25 | 103.86 | 48.51 | 265.51 | 67.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 105.57 | 51.38 | 273.92 | 70.95 |
| 20-Day Raw Stochastic | 43.90% | 33.40% | 7.71% | 9.93% | 1.80% |
| 20-Day Relative Strength | 72.09% | 50.34% | 37.51% | 40.10% | 31.67% |
| Weighted Alpha | +16.30 | -18.33 | -29.54 | +6.47 | -22.77 |
| Today's Opinion | 88% Buy | 72% Buy | 56% Sell | 40% Sell | 100% Sell |
| Previous Opinion | 100% Buy | 72% Buy | 56% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 100% Buy | 40% Buy | 8% Sell | 8% Sell | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | -7.43% since 04/09/24 | -5.79% since 04/09/24 | -1.34% since 04/09/24 | -3.15% since 04/09/24 |
| Low | 43.53 on 02/24/23 | 102.30 on 04/15/24 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 |
| High | 44.90 on 03/02/23 | 110.29 on 04/10/24 | 51.28 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 |
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | -0.52% since 03/15/24 | -7.13% since 03/15/24 | -0.79% since 03/15/24 | -8.07% since 03/15/24 |
| Low | 43.31 on 02/23/23 | 97.00 on 04/03/24 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 |
| High | 45.23 on 02/03/23 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | +1.13% since 01/16/24 | -2.78% since 01/16/24 | -12.10% since 01/16/24 | -21.22% since 01/16/24 |
| Low | 17.78 on 12/27/22 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 |
| High | 45.23 on 02/03/23 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | +12.37% since 10/16/23 | -14.97% since 10/16/23 | -7.02% since 10/16/23 | -14.47% since 10/16/23 |
| Low | 16.02 on 09/07/22 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.62 on 04/12/24 |
| High | 45.23 on 02/03/23 | 115.97 on 01/08/24 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 39,765,916 | 98,318,080 | 142,291,856 | 84,353,968 |
| Shares Outstanding, K | 20,701 | 382,880 | 2,026,759 | 535,919 | 1,245,077 |
| Annual Sales | 40,580,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -34,030,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 9,830,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -37,800,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.03 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 03/07/23 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.44 | 14.33 | 10.13 |